Recommendations for hypofractionated whole-breast irradiation
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC MEDICA BRASILEIRA
Autores
FREITAS, Nilceana Maya Aires
ROSA, Arthur Accioly
HANNA, Samir Abdalla
HANRIOT, Rodrigo de Morals
BORGES, Allisson Bruno Barcelos
GONDIM, Guilherme Rocha Melo
PELLIZZON, Antonio Cassio Assis
VERAS, Igor Moreira
ALMEIDA JUNIOR, Wilson Jose de
Citação
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.64, n.9, p.770-777, 2018
Resumo
This recommendation consensus for hypofractionated whole-breast radiotherapy (RT) was organized by the Brazilian Society of Radiotherapy (SBRT) considering the optimal scenario for indication and safety in the technology applied. All controversies and contraindication matters (hypofractionated RT in patients who underwent chemotherapy [CT], hypofractionated RT in lymphatic drainage, hypofractionated RT after mastectomy with or without immediate reconstruction, boost during surgery, hypofractionated RT in patients under 50 years old, hypofractionated RT in large breasts, hypofractionated RT in histology of carcinoma in situ [DCIS]) was discussed during a meeting in person, and a consensus was reached when there was an agreement of at least 75% among panel members. The grade for recommendation was also suggested according to the level of scientific evidence available, qualified as weak, medium, or strong. Thus, this consensus will aid Brazilian radiotherapy experts regarding indications and particularities of this technique as a viable and safe alternative for the national reality.
Palavras-chave
Referências
- Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013
- Arbor A, 2013, RAD THER ONCOL GR RT, V1005, P1
- Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7
- Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]
- BRASIL. Tribunal de Contas da Uniao (TCU), 2011, POL NAC AT ONC
- de Moraes FY, 2015, INT J RADIAT ONCOL, V92, P707, DOI 10.1016/j.ijrobp.2014.12.063
- Diwanji TP, 2017, BREAST CANCER RES TR, V165, P445, DOI 10.1007/s10549-017-4345-y
- Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2
- Haviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3
- Herbert C, 2012, INT J RADIAT ONCOL, V82, P2086, DOI 10.1016/j.ijrobp.2011.01.055
- Hickey BE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003860.pub4
- MINISTERIO DA SAUDE, 2017, EST 2018 INC CANC BR
- Shaitelman SF, 2015, JAMA ONCOL, V1, P931, DOI 10.1001/jamaoncol.2015.2666
- Sinha IP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000393
- Smith BD, 2018, PRACT RADIAT ONCOL, V8, P145, DOI 10.1016/j.prro.2018.01.012
- Smith BD, 2011, INT J RADIAT ONCOL, V81, P59, DOI 10.1016/j.ijrobp.2010.04.042
- Sun GY, 2017, INT J RADIAT ONCOL, V99, pS3, DOI 10.1016/j.ijrobp.2017.06.024
- Weltman E, 2017, REV ASSOC MED BRAS, V63, P93, DOI 10.1590/1806-9282.63.02.93
- Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260
- White J, BREAST CANC ATLAS RA
- Williamson D, 2010, RADIOTHER ONCOL, V95, P317, DOI 10.1016/j.radonc.2010.03.021
- Yarnold J, 2005, RADIOTHER ONCOL, V75, P9, DOI 10.1016/j.radonc.2005.01.005
- Yarnold J, 2018, BRIT J RADIOL, V92, DOI 10.1259/bjr.20170849
- Zhao SH, 2017, J THORAC DIS, V9, P3840, DOI 10.21037/jtd.2017.09.125
- Zhou ZR, 2015, SURG ONCOL, V24, P200, DOI 10.1016/j.suronc.2015.06.005